New Products

HAMILTON, N.J. — Dr Pepper Snapple Group will distribute a growing line of all-natural, antioxidant-infused beverages, the maker of the beverages said Tuesday.

Bai Brands, which makes the Bai 5 line, said the two companies had been working together for the last two years in select markets around the country and will now expand their partnership in most major markets.

BOWLING GREEN, Fla. — Organix-South has announced the introduction of TheraNeem Naturals Purifying Neem Facial Mask, which has the triple-power of neem leaf, oil and bark to detoxify, clarify and purify the face and neck.

This mask combines French green, bentonite and kaolin clays to cleanse and exfoliate the skin, along with botanicals that support and nourish the dermis. The product is paraben free and gluten free.

LOS ANGELES — Feline Internet celebrity Grumpy Cat is the mascot for a new pet odor-eliminating product from Accuy Natural Solutions, the company said.

Grumpty Cat's Odor Eliminator uses a liquid extract from the Yucca schidigera plant to remove odors, binding to any form of ammonia-based odors, particularly cat urine, and converting ammonia to ammonium, a non-toxic form of ammonia that lacks its odor.

NEW YORK — Music artist Pitbull has announced the launch of new scents for men and women, Pitbull Premier Fragrances, which will be available exclusively on Amazon.com beginning Dec. 1.

This new venture by Pitbull urges consumers to "Unlock the World" through scent. Inspired by taking a trip around the world, these fragrances embody the electric energy of each city and its nightlife.

DUBLIN — Drug maker Actavis hopes to become the first to market with a generic version of a topical testosterone replacement drug marketed by Eli Lilly, Actavis said.

The generic drug maker it filed with the Food and Drug Administration for approval of testosterone topical solution in the 30-mg-per-1.5 mL strength, a generic version of Lilly's Axiron. The drug is used as a replacement therapy for deficient or absent testosterone.

PITTSBURGH — Generic drug maker Mylan has launched its version of a drug for treating attention deficit hyperactivity disorder, the company said Monday.

Mylan announced the launch of dexmethylphenidate hydrochloride extended-release capsules in the 30-mg strength, a generic version of Novartis' Focalin XR. As the first company to win approval for a generic version of the drug, Mylan has 180 days in which to compete exclusively against Novartis' product.

ENTERPRISE, Utah — Southern Utah startup company, Finger Candy Nail Art, is aiming to take the nail care industry by storm with its nail art products. While the company won’t officially launch until early 2014, it is encouraging independent distributors to now sign up.

NEW YORK — A bill that would implement federal tracking and tracing of drugs and strengthen federal regulations on pharmacy compounding has passed in the Senate and will go to President Barack Obama for his signature.